Solid Biosciences to Present at the J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. SLDB today announced that Ilan Ganot, Co-Founder, Chief Executive Officer and President of Solid Biosciences will present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9^th at 7:30 am PT. Members of the management team will participate in a question and answer session following the presentation at 8:00 am PT. 

A live webcast of the presentation and question and answer session can be found under the investor relations section of Solid Biosciences' website at www.solidbio.com and will be archived there following the presentation for 30 days.

About Solid Biosciences
Solid Biosciences is a life science company focused solely on finding meaningful therapies for Duchenne muscular dystrophy (DMD). Founded by those touched by the disease, Solid is a center of excellence for DMD, bringing together experts in science, technology and care to drive forward a portfolio of candidates that have life-changing potential. Solid is progressing programs across four scientific platforms: Corrective Therapies, Disease-Modifying Therapies, Disease Understanding and Assistive Devices. For more information, please visit www.solidbio.com.

Media Contact:
Solid Biosciences
Kate Niazi-Sai
617-337-4680
media@solidbio.com

Investor Contact:
Kendall Investor Relations
Carlo Tanzi, Ph.D.
617-337-4680
investors@solidbio.com